BiotechTubeBiotechTube
Home/Pipeline/GRC 54276

GRC 54276

Asthma/COPD

Phase 2Active

Key Facts

Indication
Asthma/COPD
Phase
Phase 2
Status
Active
Company
Glenmark Pharmaceuticals

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited is a research-driven global pharmaceutical company founded in 1977 and headquartered in Mumbai, India. The company operates across the pharmaceutical value chain with significant investments in R&D, particularly in respiratory diseases, dermatology, and oncology. Glenmark has successfully developed and commercialized innovative drugs while building a strong generic pharmaceuticals portfolio across key markets including the US, Europe, and emerging markets.

View full company profile

Therapeutic Areas

RespiratoryDermatologyOncologyCardiovascularCentral Nervous System

Other Asthma/COPD Drugs

DrugCompanyPhase
SymbicortAstraZenecaApproved
ProAir (albuterol)Teva Pharmaceutical IndustriesCommercial
Generic ProAir (Albuterol HFA)Lupin LimitedApproved
Generic Advair (Fluticasone/Salmeterol)Lupin LimitedPhase 3
Generic SymbicortLupin LimitedDevelopment
Albuterol HFACiplaCommercial
Generic Advair EquivalentCiplaPhase 3